Skip to main content
. 2017 Aug 24;16:154. doi: 10.1186/s12939-017-0651-6

Table 1.

Availability of all the DM and CVD medicines and diagnostic tests in all the study sites

Medicines (N = 21 classes) Availability (%) Diagnostic tests (N = 19) Availability (%)
UFH 20.1 Microalbuminuria 6.8
Isosorbide mono nitrate 27.8 Serum ketones 11.4
LMWH 31.9 Serum natriuretic peptides 11.4
Intermediate insulin 34.7 Echocardiography 34.1
Hydralazine 47.2 Coagulation profile 36.4
Pre mixed insulin 60.1 Serum troponin testing 43.2
Warfarin 64.6 HbA1c testing 43.2
Soluble insulin 68.8 Thyroid function tests 43.2
ARB-thiazide diuretics 82.6 Electrocardiography 54.6
Digoxin 84.0 Uric acid testing 56.8
Statins 84.0 Lipid profile 65.9
ARB 86.8 Creatinine 86.4
Spironolactone 87.5 Urea 86.4
Benzathine penicillin 87.5 Serum electrolytes 88.6
Furosemide 89.6 Chest X-ray 88.6
Thiazide diuretics 94.4 Liver function tests 95.5
Anti platelet drugs 95.1 Glucometers 97.7
ACEI 96.5 CBC testing 97.7
Beta blockers 97.2 Urinalysis 100
CCB 99.3
OHA 100

UFH Unfractionated heparin, LMWH Low molecular weight heparin, ARB Angiotensin II receptor blockers, ACEI Angiotensin converting enzyme inhibitors, CCB Calcium channel blockers, OHA Oral hypoglycaemic agents, HbA1c Glycated haemoglobin